Eugene

[email protected]

LATEST

AbbVie, Allergan Receive Second Request from FTC for More Info in Pending $63-Bn Merger
By

By
AbbVie and Allergan have each received a second request for additional information from the US Federal Trade Commission (FTC) in connection with AbbVie’s pending $63-billion acquisition of Allergan, which was…

Global Pharma Briefs: News from Europe, Asia and the Middle East
By

By
A roundup of developments and latest news from Canada (Health Canada), Germany (Merz and Oncotec), India (Lupin) and the US (Darmerica). Canada Health Canada Requests Companies Stop Ranitidine Distribution for…

PCI Pharma Expands; Almac in Blockchain Working Group
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Colorcon, PCI Pharma Services, Almac and AMRI. Formulation Development/Drug Product Manufacturing Colorcon Launches $50-Million Venture Capital Fund Colorcon, an…

FDA Issues Guidances on Digital Health Tools
By

By
The US Food and Drug Administration (FDA) has released a suite of guidances to continue to encourage innovative approaches to the development of digital health tools and to advance the…

Novo Nordisk and Ardelyx Get FDA Nod; Biogen, Eisai In Late-Stage Setback
By

By
Novo Nordisk gets FDA approval for an oral form of semaglutide, a drug to treat Type II diabetes, and Biogen and Eisai have late-stage setback for Alzheimer’s drug. Novo Nordisk…

GSK To Invest $120 Million in US Biopharma Mfg Facility
By

By
GlaxoSmithKline (GSK) is investing $120 million to expand its manufacturing facility in Upper Merion, Pennsylvania to support the delivery of the company’s pipeline for cancer medicines and other specialty diseases.…

US House Speaker Nancy Pelosi Introduces Drug Pricing Plan
By

By
The US House of Representatives Speaker Nancy Pelosi (D-Calif.) has introduced a proposed drug pricing plan (H.R.3, The Lower Drug Costs Now Act) to address the cost of prescription drugs.…

BI Partners with Inflammasome Therapeutics to Develop Retinal Disease Therapies
By

By
Boehringer Ingelheim (BI) and Inflammasome Therapeutics, a developer of therapies for degenerative diseases, have entered into a co-development and license agreement to develop up to three therapies for patients with…

Sandoz, Torrent Pharmaceuticals Recall Products for Nitrosamine Impurities
By

By
Sandoz, the generics arm of Novartis, and Torrent Pharmaceuticals, an Ahmedabad, India-based pharmaceutical company, have made voluntary recalls of certain products, respectively ranitidine and losartan, for containing certain nitrosamine impurities.…

Congress Asks FTC to More Closely Examine Pharma Mega Mergers
By

By
US Senator Amy Klobuchar (D-MN), Ranking Member of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, and eight other senators, have sent a letter to US Federal…